Obesity epidemic feeds weight-loss product sales
Sales of diet-aid and weight-loss solutions for the past year have been relatively flat, but a confluence of factors — childhood obesity approaching “epidemic” status combined with the real need to reduce escalating healthcare costs connected to obesity — could become a real driver behind weight-loss products in the coming year.
Overall, sales of weight-control products (tablets and liquid) totaled $1.2 billion, up 0.2%, for the 52 weeks ended Oct. 31, 2010, across food, drug and mass outlets, according to SymphonyIRI Group. Two of the more notable up-and-coming brands within diet aid include a company parlaying its ready-to-eat cereal brand heritage into total weight-loss solutions and one of the TV fitness gurus from the popular weight-loss reality show “The Biggest Loser.”
Kellogg’s has posted 12.7% growth, reaching sales of $292.2 million, across three SKUs: Kellogg’s NutriGrain bars and Kellogg’s Special K protein shakes and bars. And Basic Research has helped establish its Jillian Michaels line of weight-loss solutions as the No. 2 diet aid on the shelf behind GlaxoSmithKline’s Alli.
According to the Centers for Disease Control and Prevention, the prevalence of obesity among children ages 6 years to 11 years increased from 6.5% in 1980 to 19.6% in 2008. The prevalence of obesity among adolescents ages 12 years to 19 years increased from 5% to 18.1%. Recent research published in the journal Childhood Obesity affirmed the link between overweight children and the increased risk of obesity, heart disease, Type 2 diabetes and other cardiovascular and metabolic disorders in adulthood.
The article above is part of the DSN Category Review Series.
For the complete Weight-Control Buy-In Report, including extensive charts, data and more analysis, click here.
Jim Hamilton joins CRN’s board
WASHINGTON — The Council for Responsible Nutrition on Monday elected Jim Hamilton, president of DSM Nutritional Products USA, to chair of the association’s board of directors.
Hamilton, who will hold the chairman post through 2012, succeeds Mark LeDoux, CEO of Natural Alternatives International. LeDoux will continue to serve on the board as immediate past chair.
“With a new Congress and increased scrutiny from the regulatory agencies, it is imperative that we continue to work with our champions on Capitol Hill and educate new staffers not familiar with the Dietary Supplement Health and Education Act, and that we urge for stronger enforcement of the laws in place and step up our own self-regulatory efforts,” Hamilton stated. “I look forward to working with my colleagues on CRN’s board to continue to fulfill CRN’s mission.”
CRN’s new board of directors is comprised of 31 member company representatives and CRN president and CEO Steve Mister. Also elected to serve alongside Hamilton are chair-elect John Blair from NSA; treasurer Ron Fugate from Alacer Corp.; and secretary Kristen Blanchard from Nutramax Labs.
CHPA announces executive changes
WASHINGTON — The Consumer Healthcare Products Association on Monday named Bill Head as the association’s VP government affairs, effective Jan. 17, and promoted David Spangler as the association’s SVP policy, general counsel and secretary, effective immediately.
Reporting to CHPA president and CEO Scott Melville, Head will be responsible for the association’s state and federal government affairs departments and its political action committee, and will serve as a member of the association’s senior management team. He succeeds Andrew Fish, who recently joined AdvaMed Diagnostics as its executive director.
“Bill’s extensive and diverse background in state and federal government affairs, health care and public policy is the kind of experience we need to lead the CHPA government affairs team at this critical time,” Melville said. “Throughout his professional career, Bill has demonstrated that he is a strong leader who will bring well-tuned political instincts and legislative savvy to this critical function of our association.”
Spangler will continue to serve as a member of the association’s senior management team, overseeing policy initiatives and international efforts, while taking on the added role of directing the association’s legal affairs. Regarding Spangler, Melville said, “He is widely respected for his work both at home and abroad, and he is well prepared to take on the additional role of general counsel and secretary, where he will work closely with me on board matters while overseeing the legal affairs function.”
Head most recently led the government affairs department of the Generic Pharmaceutical Association. Prior to that, he served as a lobbyist in the healthcare insurance and pharmaceutical benefit management industries, as an adviser to former Gov. Ben Nelson of Nebraska and as a lieutenant in the United States Navy.
Head holds a J.D. from the University of Nebraska College of Law, an M.A. from the University of Nebraska and a B.A. from the University of Maryland.
Spangler joined the CHPA in 1984 as a legislative analyst. He subsequently served in a number of roles for the association in the president’s office, project management, international affairs and legal affairs before assuming his position as SVP policy and international affairs in 2006. He is a graduate of Miami University of Ohio and the George Washington University National Law Center.